Literature DB >> 16603926

Pedunculopontine nucleus electric stimulation alleviates akinesia independently of dopaminergic mechanisms.

Ned Jenkinson1, Dipankar Nandi, Rebecca Oram, John F Stein, Tipu Z Aziz.   

Abstract

The symptom of Parkinson's disease that is most disabling and difficult to treat is akinesia. We have previously shown that low-frequency stimulation of the pedunculopontine nucleus can alleviate such akinesia in a macaque rendered Parkinsonian using 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine. Here, we have extended that study to show that adding stimulation of the pedunculopontine nucleus to levodopa treatment in this Parkinsonian monkey increased its motor activity significantly more than levodopa alone. This additivity suggests that pedunculopontine nucleus stimulation may improve movement by acting at a site downstream from where levodopa therapy affects the basal ganglia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16603926     DOI: 10.1097/00001756-200604240-00016

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  18 in total

Review 1.  The pedunculopontine nucleus as a target for deep brain stimulation.

Authors:  Clement Hamani; Elena Moro; Andres M Lozano
Journal:  J Neural Transm (Vienna)       Date:  2010-12-31       Impact factor: 3.575

Review 2.  Pedunculopontine stimulation from primate to patient.

Authors:  Erlick A C Pereira; Dipankar Nandi; Ned Jenkinson; John F Stein; Alexander L Green; Tipu Z Aziz
Journal:  J Neural Transm (Vienna)       Date:  2011-03-30       Impact factor: 3.575

3.  Magnetic resonance diffusion tensor imaging for the pedunculopontine nucleus: proof of concept and histological correlation.

Authors:  A T D L Alho; C Hamani; E J L Alho; R E da Silva; G A B Santos; R C Neves; L L Carreira; C M M Araújo; G Magalhães; D B Coelho; M C Alegro; M G M Martin; L T Grinberg; C A Pasqualucci; H Heinsen; E T Fonoff; E Amaro
Journal:  Brain Struct Funct       Date:  2017-03-10       Impact factor: 3.270

Review 4.  The pedunculopontine tegmental nucleus: implications for a role in modulating spinal cord motoneuron excitability.

Authors:  Eugenio Scarnati; Tiziana Florio; Annamaria Capozzo; Giuseppina Confalone; Paolo Mazzone
Journal:  J Neural Transm (Vienna)       Date:  2010-12-16       Impact factor: 3.575

5.  Effects of unilateral pedunculopontine stimulation on electromyographic activation patterns during gait in individual patients with Parkinson's disease.

Authors:  Pietro Caliandro; A Insola; E Scarnati; L Padua; G Russo; E Granieri; P Mazzone
Journal:  J Neural Transm (Vienna)       Date:  2011-09-09       Impact factor: 3.575

Review 6.  Subthalamic nucleus versus pedunculopontine nucleus stimulation in Parkinson disease: synergy or antagonism?

Authors:  M U Ferraye; B Debû; V Fraix; P Krack; S Charbardès; E Seigneuret; A-L Benabid; P Pollak
Journal:  J Neural Transm (Vienna)       Date:  2011-06-22       Impact factor: 3.575

Review 7.  Basal ganglia, movement disorders and deep brain stimulation: advances made through non-human primate research.

Authors:  Thomas Wichmann; Hagai Bergman; Mahlon R DeLong
Journal:  J Neural Transm (Vienna)       Date:  2017-06-10       Impact factor: 3.575

8.  Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat.

Authors:  Irene Avila; Louise C Parr-Brownlie; Elena Brazhnik; Edward Castañeda; Debra A Bergstrom; Judith R Walters
Journal:  Exp Neurol       Date:  2009-12-04       Impact factor: 5.330

Review 9.  Neural Control of Walking in People with Parkinsonism.

Authors:  D S Peterson; F B Horak
Journal:  Physiology (Bethesda)       Date:  2016-03

10.  A block to pre-prepared movement in gait freezing, relieved by pedunculopontine nucleus stimulation.

Authors:  Wesley Thevathasan; Alek Pogosyan; Jonathan A Hyam; Ned Jenkinson; Marko Bogdanovic; Terry J Coyne; Peter A Silburn; Tipu Z Aziz; Peter Brown
Journal:  Brain       Date:  2011-07       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.